GlassScriptPhysician profile
Kristine Jeter
NPI 1154953875
$2,926.98
in general payments reported to CMS, 2019-2025
19 companies · $1,249 in 2025
The $1,249 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.05 · 2022: $122 · 2023: $851 · 2024: $660 · 2025: $1,249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,760.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $692.25 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $538.51 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $430.08 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $280.68 | 2023-2025 | Wegovy |
| Lilly USA, LLC | $201.20 | 2022-2024 | Mounjaro, Zepbound, Jardiance |
| Otsuka America Pharmaceutical, INC. | $137.88 | 2025 | Rexulti |
| Axsome Therapeutics, INC. | $136.64 | 2025 | Auvelity |
| Pfizer INC. | $118.47 | 2023-2025 | |
| Glaxosmithkline, LLC. | $64.32 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Shield Therapeutics INC | $63.37 | 2024-2025 | |
| Antares Pharma, INC. | $59.63 | 2022-2024 | Xyosted, Tlando, Nocdurna |
| Halozyme INC | $41.95 | 2023 | |
| Inspire Medical Systems, INC. | $30.18 | 2024 | Inspire |
| Kowa Pharmaceuticals America, INC. | $28.51 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.53 | 2023 | Trintellix |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $23.40 | 2025 | Repatha |
| Amarin Pharma, INC. | $20.54 | 2023 | |
| Idorsia Pharmaceuticals US INC | $18.77 | 2022 | |
| Azurity Pharmaceuticals, INC. | $17.07 | 2023 | Edarbi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristine Jeter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.